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A variety of mass spectrometric techniques have been employed in the study of a series of
structurally similar compounds used in the treatment of hypertension. The compounds,
known collectively as angiotensin-converting enzyme (ACE) inhibitors, all share the amino
acid residue proline or some variant thereof, as a common structural element. The gas phase
fragmentation behavior of these compounds has been explored systematically using various
instruments and techniques. An interesting dissociation process (rearrangement) unique to
one of the compounds, lisinopril, has been investigated using isotopic labeling experiments
and exact mass measurements. The general nature of the process has been probed through
both the positive and negative ion analyses of fourteen related compounds exhibiting
structural homology. (J Am Soc Mass Spectrom 2004, 15, 1300–1314) © 2004 American
Society for Mass SpectrometryThe metabolic transformations of various angio-tensins in vivo constitute some of the most im-portant biological processes involved in the dis-
ease state of hypertension (high blood pressure). The
pivotal process in the angiotensin cascade is the cleav-
age of the decapeptide angiotensin I to produce the
potent vasoconstrictor angiotensin II, an octapeptide.
This hydrolytic elimination of the two-residue carboxyl-
terminus dipeptide from angiotensin I is catalyzed by
the angiotensin-converting enzyme (ACE), a zinc met-
allopeptidase [1]. Effective management of high blood
pressure has been achieved over the past 20 years
through the use of a class of orally active therapeutic
agents that inhibit the production of angiotensin II by
competitively binding to the active site of the ACE.
Until recently, the structure of the ACE was unknown
[2]. Previous supposition about the structure of the
active binding site (by analogy to that of carboxypepti-
dase A [3]) led to the rational design of carboxyalkanoyl
and mercaptoalkanoyl derivatives that mimic the
dipeptide liberated from angiotensin I [4]. Many of the
molecules in the class [5–7] contain the amino acid
proline (or a proline-like surrogate), the carboxy group
of which interacts with a positively charged atom or
residue at the binding site. Two other structural ele-
ments thought to be necessary for effective competitive
binding of inhibitor molecules are (1) an amide car-
bonyl oxygen (that hydrogen bonds with an acidic
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nucleophilic moiety (e.g., atoms such as sulfur, nitro-
gen, or phosphorous) to strongly coordinate with the
zinc cation of the metalloenzyme.
Mass spectral analysis of therapeutic ACE inhibitors
has largely focused on the detection and quantitation of
these compounds in pharmaceutical preparations [8] or
various biological matrices, in order to establish the
pharmacokinetic and metabolic profiles of these agents
[9–16]. Two publications have detailed the interactions
of some of these molecules with metal ions, using mass
spectrometry and ultraviolet spectroscopy to evaluate
their potential role as radical scavengers [17, 18]. At
least four compounds in this class have been the focus
of studies where collision-induced dissociation and
tandem mass spectrometry (MS/MS) have been used to
probe their dissociation reactions [19, 20]. Two of those
compounds, lisinopril and zofenapril, exhibited inter-
esting rearrangement reactions in the unimolecular
dissociation chemistry of their protonated molecules
([M  H]) under conditions of low-energy collisional
activation.
In this paper we report a systematic comparison of
the collision-induced fragmentation behavior for the
molecular ions (both cations, [M  H], and anions, [M
 H]) of fourteen compounds belonging to the ACE
inhibitor class (Figure 1). The unimolecular gas-phase
chemistry of the analytes was explored using several
types of instruments to obtain generational relation-
ships (from sequential dissociation and precursor ion
experiments), elemental composition (from exact m/z
measurements), and the number of labile hydrogen
atoms (through deuterium incorporation experiments).r Inc. Received February 19, 2004
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Accepted May 24, 2004
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1301J Am Soc Mass Spectrom 2004, 15, 1300–1314 FRAGMENTATION OF ACE INHIBITORSThe purpose of these experiments was to investigate the
relationship between the structural homology responsi-
ble for biological activity and the gas-phase fragmenta-
tion behavior of these molecules, and thereby contrib-
ute additional insight into conclusions drawn from
previous work about the dissociation chemistry of lis-
inopril. These results may also be useful in future
fundamental or analytical studies of these compounds,
being what may be the first report of the fragmentation
behavior of the anions ([M  H]) produced by depro-
tonation of the ACE inhibitors and their related com-
pounds.
Experimental
Mass Spectrometry
Atmospheric pressure ionization (API) mass spectro-
metry experiments were performed using several in-
struments, including a ThermoFinnigan (San Jose, CA)
TSQ7000 triple quadrupole mass spectrometer, a Ther-
moFinnigan LCQ quadrupole ion trap mass spectrom-
eter, and a Waters/Micromass (Manchester, UK)
QTOF2 quadrupole/time-of-flight mass spectrometer.
The TSQ7000 and LCQ ITMS were equipped with the
manufacturer’s API2 atmospheric pressure ionization
sources. APCI conditions (positive and negative) were
as follows: heated vaporizer, 450 °C; heated capillary,
250–300 °C; discharge voltage, 4.5 kV; corona discharge
current, 5 A; HPLC eluent flow rate, 1 mL per min;
nebulizing and auxiliary gas, nitrogen; nebulizing and
auxiliary gas pressures, 80 and 20 psi, respectively. ESI
conditions were as follows: heated capillary, 250–
300 °C; electrospray voltage, 5 kV; HPLC eluent flow
Figure 1. ACE inhrate, 1 mL per min; nebulizing and auxiliary gas,
nitrogen; nebulizing and auxiliary gas pressures, 80 and
20 psi, respectively. Collision-induced dissociation
(CID) experiments on the TSQ7000 were carried out at
a measured pressure of 0.7 mTorr (multiple collision
conditions, measured using a convectron gauge) using
offset potentials of between 20 and 35 V (i.e., collision
energies of 20–35 eV in the laboratory frame of refer-
ence, Elab) with xenon as collision gas. Product-ion
spectra were acquired using either “unit” resolving
power in the precursor ion selection stage (approximate
peak width of 0.7 m/z unit, full-width at half-maximum
definition) or a resolving power for Q1 that passed
several of the ions in the isotopic envelope into the
collision region. This condition produces product-ion
spectra that contain isotopic distribution information
that is lost when precursor ions are isolated with unit
resolving power. In the deuterium incorporation exper-
iments, the Q1 resolving power was set at its typical
value (passing ions of only a single m/z value), avoiding
potential interpretive ambiguities. Spectra were re-
corded using scan ranges suitable for the relative mo-
lecular mass (Mr) of each particular analyte. Precursor-
ion CID spectra were also acquired with unit resolving
power settings for both Q1 and Q3 in order to explicitly
define some of the familial relationships between the
various dissociating ions. Scan rates for both mass
spectra and product-ion spectra (MS/MS) typically
were on the order of 1 m/z unit per ms.
CID experiments on the LCQ ion trap mass spec-
trometer (ITMS) were conducted using the helium bath
gas at the normal operating pressure of the instrument
and an ion excitation energy (radial kinetic energy) of
r compounds 1–14.
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were acquired with an isolation window setting that
resulted in excitation of several of the species in the
isotopic envelope of the precursor ion. As described
above, this condition produces product-ion spectra that
contain isotopic distribution information that is lost
when precursor ions are isolated with unit resolution.
However, for the deuterium incorporation experiments,
the isolation window was narrowed so that only ions
representing the 12C isotopic [M  H] signal were
dissociated.
Exact mass measurements were made using a Wa-
ters/Micromass quadrupole time-of-flight (QTOF2)
mass spectrometer. Ionization was affected using the
manufacturer’s Z-SPRAY source operating in the pneu-
matically assisted electrospray ionization mode. Elec-
trospray ionization (ESI) conditions were as follows:
source block temperature, 150 °C; desolvation temper-
ature, 300 °C; capillary voltage, 3.0 kV; cone voltage, 30
V; eluent flow rate, 2–10 L per min; collision gas,
argon; collision energy (Elab), 20–30 eV. Beam transmit-
tance was reduced approximately 50–70% by admit-
tance of collision gas. Spectra were obtained with MS1
(Q1) set to transmit a monoisotopic precursor ion beam
(i.e., unit mass resolving power) and the time-of-flight
(TOF) mass analyzer set to acquire from m/z 40 to 600.
Spectra were acquired in continuum (profile) mode
with a 1 s acquisition duration (summing of multiple
scans) and a 0.1 s interacquisition delay. The pusher
repetition rate was 30 kHz and the sampling rate of the
analyzer was 1 GHz [21]. Single point lock mass correc-
tion was used for exact mass (m/z) determination, and
the parent ion, [M  H] was utilized as the lock mass
for product ion measurements. The measured resolving
power was approximately 5200 (full-width at half-
maximum (FWHM) at m/z 406).
The samples were introduced into ESI sources using
either a Harvard Apparatus (Holliston, MA) syringe
pump or an Agilent (Palo Alto, CA) HPLC system.
Sample solutions that accommodated direct infusion
were introduced at flow rates on the order of 2–10 L
per min. When sample mixtures warranted chromato-
graphic separation, compounds were eluted from a
reverse-phase C18 column (50 mm  2 mm, 3  parti-
cles, Phenomenex, Torrance, CA) operating at a flow
rate of 0.7 mL/min. The flow rate of the effluent
introduced into the ESI source of the QTOF2 instrument
was 0.2 mL/min.
Chemicals
Compounds 3, 9–14 were obtained as commercially
available products. Sample preparation involved disso-
lution of the dosage form (in water or 50:50 water/
acetonitrile) and filtration prior to injection onto the
HPLC column. Compound 1 was obtained as drug
substance, which was dissolved, filtered and infused
directly. Sample solutions were prepared at an approx-
imate concentration of 1 mg/mL. Injection volumeswere typically 1 L. Compounds 2, 4–8 were prepared
in situ by treating the sample solutions of the respective
ethyl esters with 0.1 N aqueous HCl. In general, a
reaction time of approximately 24–48 h (ambient tem-
perature) was sufficient to partially hydrolyze the ester,
producing an acceptable quantity of the desired diacid
compounds. The mobile phase for the standard positive
and negative ion ESI experiments was comprised of
water, acetonitrile and formic acid, in proportions suit-
able for some modest chromatographic retention, rang-
ing from 75:25:0.05 (vol/vol/vol) to 95:5:0.05 (vol/vol/
vol). The MilliQ water was replaced with D2O (99.9
atom% D) for the deuterium exchange experiments. All
solvents, gases and other reagents were obtained com-
mercially and used as received—water (Millipore Mil-
liQ UF purification system, Billerica, MA); acetonitrile
and formic acid (EM Science, Hawthorne, NY); deute-
rium oxide (Aldrich Chemicals, Milwaukee, WI); hy-
drochloric acid (Mallinckrodt, Paris, KY).
Results and Discussion
Positive Ion Study
Investigation of the ACE inhibitors was undertaken
after an unexpected rearrangement was observed for
the protonated molecule ([M  H]) of lisinopril, 1.
Such rearrangement processes are of interest from the
perspective of fundamental gas-phase ion chemistry, as
well as for the impact they have on the interpretation of
collision-induced dissociation spectra in the context of
characterization of unknown organic compounds. Flo-
reˆncio and coworkers [19] reported the fragmentation
behavior of lisinopril, 1, under low-energy collision-
induced dissociation conditions. Among the dissocia-
tion reactions exhibited by the [M  H] ion (m/z 406)
of lisinopril (Figure 2), elimination of neutral C5H7NO
(m/z 309) was particularly interesting since it requires
that a functional group migration/rearrangement must
either precede or accompany the elimination of dihy-
Figure 2. Product ion collision-induced dissociation (CID)
MS/MS spectrum for the [M-d0  H]
 ion (m/z 406) (upper panel)
and [M-d5  D]
 (m/z 412) (lower panel) of lisinopril.
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measurements and deuterium exchange experiments
confirmed the elemental composition of the leaving
neutrals. It cannot be established unequivocally from
these data whether the elimination reaction produces
two molecules (dihydropyrrole and CO) or a single
neutral molecule (dihydropyrrolecarbaldehyde). The
measured mass-to-charge ratio of 309.1808 compared
favorably with the calculated (expected) value of
309.1809 (accuracy  0.4 ppm; standard deviation 
1.1 ppm). Replacement of the aqueous component of
the HPLC eluent with D2O resulted in a complete
exchange of all labile protons in the analyte molecule
[22]. For lisinopril, the deuterium exchange experiment
produced the expected mass shift of 6 Da (m/z 406,
[M-d0  H]
 to m/z 412, [M-d5  D]
). Collisional
activation of the 412 ions produces product ions at m/z
315 that contain all six of the incorporated deuterons,
indicating no labile hydrogen atoms in the eliminated
neutrals. The authors of the previous lisinopril study
proposed a hydroxyl group transfer as the rearrange-
ment process that accompanies (or precedes) the elim-
ination of C5H7NO. A transfer of the hydroxyl group
from the proline carboxylic acid carbon atom to the
carbonyl carbon atom of the lysine-proline amide bond
requires a five-centered transition state (Structure A,
Scheme 1). This process depends on protonation of the
amide oxygen atom, followed by a concerted hydroxy
Scheme 1. Possible mechanisms for the rearra
from the [M  H] ion (m/z 406) of lisinopril. T
in a previous study [19].group transfer to the amide carbonyl carbon with
elimination of dihydropyrrole and carbon monoxide.
Given the relative proton affinities of the three nitrogen-
containing functional groups in the molecule (assumed
to the most probable sites of protonation), it seemed
improbable that a large enough portion of the [MH]
ion population attained the necessary structure to initi-
ate the fragmentation scheme leading to Structure A
(Scheme 1). If however, the terminal lysine amine group
was the predominate site of protonation, then some
considerable degree of proton “mobility” would need
to precede fragmentation in order to produce the req-
uisite protonated amide ion structure. Any “interac-
tion” or proton transfer between the lysine amine group
and the amide group would require an unusual nine-
centered transition state geometry. The respective pro-
ton affinities of these two functional groups also do not
favor the aforementioned proton transfer. Another pos-
sible explanation for the interesting C5H7NO elimina-
tion would invoke a charge-remote mechanism. This
mechanism depends neither on the initial location of the
ionizing proton nor its mobility, in this case from a
more basic functional group to a less basic functional
group. An interesting aspect of the mechanism summa-
rized in Scheme 1 (culminating in Structure B) is the
transfer/rearrangement of the carboxylic acid group
(i.e., electrophilic attack of a carboxylic acid carbonyl
carbon on the lone pair electrons of a secondary nitro-
ent accompanying the elimination of C5H7NO
echanism leading to Structure A was proposedngem
he m
1304 BURINSKY AND SIDES J Am Soc Mass Spectrom 2004, 15, 1300–1314gen atom through a six-centered transition state). Dif-
ferentiation of isomeric ion structures, such as the two
shown in Scheme 1, based on their CID product ion
spectra depends on the presence of one or more signals
that uniquely elucidates one of the putative structures.
Unfortunately, isomeric ions are often not differentiable
a priori, because many (if not all) of the dissociation
products can be rationalized from any of the possible
structures. Such is the case for the m/z 309 fragment in
the CID product ion spectrum of lisinopril. Neither
product ion spectra, deuterium exchange experiments,
nor exact m/z measurements can provide unequivocal
evidence in favor of one of the possible structures, (A or
B), over the other.
The CID spectra of the deuterated and non-deuter-
ated lisinopril molecular ions also exhibit other inter-
esting dissociation processes. The primary amino group
on the lysine side-chain is the likely site of protonation
leading to the elimination of ammonia (4063 389 for
lisinopril-d0 and 412
3 392 for lisinopril-d5). The m/z
360 signal in the spectrum of protonated lisinopril-d0
(406 3 360) presumably results from a competing
reaction channel, loss of HCO2H in a single step pro-
cess, or consecutive losses of water and CO, although
no signal is observed for the water loss product (4063
388). The analogous result (412 3 364, loss of
DCO2D, or loss of D2O and CO) was observed in the
lisinopril-d5 product ion spectrum. The appearance of
this dissociation channel was unexpected considering
the intrinsic basicity of the three nitrogen-containing
functional groups in the molecule. The incorporation of
two deuterons into the eliminated formic acid (or
water) molecule requires that either a portion of the [M
 H/D] ion population is protonated/deuterated at
one of the phenylbutyric acid oxygen atoms, or that the
ionizing proton/deuteron is mobile enough [23] to
migrate to the carboxylic acid group after collisional
excitation but prior to fragmentation. The presence of
two carboxylic acid groups in compounds 1, 2, 4–8
provides two possible sources for the lost formic acid
molecule. Interestingly, the formic acid loss originates
exclusively from the carboxylic acid group in the N-
terminus blocking group, as indicated by the corre-
sponding loss of ethylformate from the ethyl ester
compounds, 9–14. There is no signal corresponding to
the loss of formic acid in the product ion spectra of
those compounds. The aforementioned competitive
processes (NH3 and HCO2H) combine in a consec-
utive (or concerted) fashion (either 406  NH3 
HCO2H or 406
  HCO2H  NH3) to generate the
product ion at m/z 343. Sequential dissociation experi-
ments (so called MS/MS/MS or MS3) conducted using
both ion trap and QTOF mass spectrometers (shown in
Table 1) confirm that both channels are operative,
although the relative abundance of the m/z 343 ion
signal is greater in the MS3 spectrum of 360 (i.e., 406
3 360 3 fragments, 100% relative abundance in the
ITMS spectrum and 30% relative abundance in the
QTOF spectrum) than in that of 389 (i.e., 4063 3893 fragments, 8% relative abundance in the ITMS spec-
trum and 3% relative abundance in the QTOF spec-
trum). Since the ionizing deuteron can only be lost with
one of the two neutral molecules eliminated during the
consecutive dissociation processes, one of the elimina-
tion reactions must be charge-remote in nature, not
relying on the ionizing proton. This fact is confirmed by
the deuterium exchange product ion spectrum, which
exhibits a signal at m/z 345 (412  ND3  HCO2D or
412  DCO2D  ND2H). Close examination of the
345 isotopic distribution reveals some appreciable
signal intensity at the adjacent m/z values of 344 and
346. The appearance of these signals depends upon
considerable mobility of the exchangeable deuterons.
One case requires that both reactions are charge-remote
(not involving the ionizing deuteron) resulting in the
loss of HCO2D and ND2H and producing a signal at m/z
346. The second case depends upon participation of an
exchangeable deuteron from one of the other functional
groups, explaining the signal at m/z 344 (due to the
consecutive losses of DCO2D and ND3).
The most diagnostic fragmentation process for
peptide and protein ions is cleavage of the amide
bond. This process produces the well-known N-
terminal b ([H2NCH(R)CO]
) and C-terminal y
([H3NCH(R)CO2H]) ions [24] that provide the blue-
print for primary amino acid sequence determinations
by mass spectrometry. Although only dipeptides, all of
the ACE inhibitor compounds in this study (with the
exception of captopril) have the potential for exhibiting
one or both of the characteristic peptide cleavage ions.
Protonated lisinopril displays the b ion signal in its CID
product ion spectrum (m/z 291 for lisinopril-d0 and m/z
295 for lisinopril-d5), with no evidence of the compli-
mentary y ion signal (m/z 116). The peptide bond
cleavage occurs primarily from the intact protonated
molecule ([MH]), since the 291 ion appears in only
one (and at low abundance) of the MS3 spectra summa-
rized in Table 1. A related fragmentation reaction for
peptide ions is a ion ([H2NCH(R)]
) formation. This
fragment ion forms either by direct cleavage of the
peptide backbone between the -carbon and the amide
carbonyl carbon, or through a series of two consecutive
cleavages, with b ion formation followed by elimination
of carbon monoxide. The 263 product ion in the
protonated lisinopril MS/MS spectrum is just such an a
ion, as verified by the analogous m/z 267 in the deute-
rium exchange product ion spectrum (Figure 2, lower
panel). The first of the two remaining significant signals
in the product ion spectrum of the protonated lisinopril
molecule is m/z 246. This ion results from several
consecutive dissociation processes involving the proline
residue (b-ion formation), the carbonyl group adjacent
to the proline residue (a-ion formation), and the termi-
nal amino group of the lysine side chain (406 3 389
3 274 3 246 or 406 3 291 3 263 3 246). The
isotopic distribution of the deuterium labeled dissocia-
tion product signal at m/z 247 indicates some scram-
bling or mobility of the deuterons. As shown in Scheme
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dissociation of the fully deuterated 412 precursor ion.
The greater abundance of the m/z 247 ion indicates that
a fifth deuteron is transferred from one of the other
functional groups. The other signal of significant inten-
sity in the isotopic distribution (m/z 249) represents the
elimination of neutrals that are deficient in deuterons,
possessing only three. Two of these three processes
reveal unanticipated mobility of deuterons and other
hydrogen atoms in the precursor ion structure, presum-
ably as a consequence of collisional activation. In one
case, more than the predicted number of deuterons is
lost and in the other case, fewer than the predicted
number of deuterons is lost. In either case, one of the
dissociation reactions occurs in the absence of the
ionizing deuteron (i.e., charge remote). The neutrals
containing fewer that the expected number of deuterons
result from an intramolecular back exchange reaction.
This outcome reflects the replacement of a deuteron in
either the lysine side chain ND2 or the carboxylic acid
OD with a “non-exchangeable” hydrogen atom from
elsewhere within the ion.
Table 1. Summary of the sequential fragmentation spectra (MS3
protonated lisinopril ([M  H]). Spectra were acquired on both
mass spectrometers
Quadrupole ion trap
sequential
fragmentation
summary
406 3 389 3 frags a 246 (100) 291
406 3 360 3 frags a 200 (4) 217
406 3 343 3 frags a 200 (90) 209
406 3 309 3 frags a 130 (8) 246
406 3 291 3 frags 84 (2)b 245 (100) 291
406 3 263 3 frags 84 (100) 130 (10) 136
406 3 246 3 frags 84 (20) 117 (7) 129
Collision energy (lab)  1.6 V in both stages of collisional activation fo
aThese values fall below the low m/z cut-off value [26] in the product i
bThis value is close to the low m/z cut-off value cut-off value, which m
Quadrupole/time-of-
flight sequential
fragmentation
summary
406 3 389 3 frags 142
(10)
200
(4)
218
(8)
246
(100)
406 3 360 3 frags 84
(100)
96
(15)
116
(11)
130
(13)
406 3 343 3 frags 96
(40)
200
(100)
343
(22)
406 3 309 3 frags 84
(100)
130
(25)
142
(8)
202
(10)
406 3 291 3 frags 84
(90)
117
(15)
129
(10)
148
(10)
406 3 263 3 frags 84
(100)
142
(5)
246
(6)
263
(1)
406 3 246 3 frags 84
(20)
117
(10)
142
(100)
200
(12)
Collision energy (lab)  22 V; cone voltage  40 V.
Note: there is no mass selection prior to the first stage of collisional aPerhaps the most interesting signal in the CID prod-
uct ion spectrum of the protonated lisinopril molecule is
the base peak at m/z 84. This ion also produces a
dominant signal in the MS3 spectra of five of the seven
significant product ions of lisinopril. In particular, the
presence of this ion in the MS3 spectrum of the 246 ion
(406 3 246 3 84) supports a tetrahydropyridine
structure, although other isomeric structures cannot be
ruled out. The complexity of the processes responsible
for the formation of the m/z 84 product ion is revealed
upon examination of the CID product ion spectrum of
[lisinopril-d5]D
, m/z 412. The signal displays a surpris-
ingly complex isotopic distribution, showing significant
signal intensity at m/z 85 (C5H9DN
), m/z 86
(C5H8D2N
), m/z 87 (C5H7D3N
), and m/z 88
(C5H6D4N
) with relative abundances of 30, 100, 80,
and 15%, respectively (see Figure 2, lower panel). The
variety of species revealed by the labeling experiment
indicates multiple reaction pathways and multiple pre-
cursor ions of different structure or sites of protonation.
The higher mass isotopomers at m/z 87 and 88 are
particularly interesting. The incorporation of three or
he major ions observed in the product ion MS/MS spectrum of
rupole ion trap (ITMS) and quadrupole/time-of-flight (QTOF)
value (relative abundance)
326 (5) 343 (8) 370 (22) 389 (2)
246 (11) 263 (12) 343 (100) 360 (4)
343 (100)
263 (8) 292 (100) 309 (-)
246 (60) 263 (-)
142 (100) 200 (15) 218 (34) 246 (25)
S experiments.
an range.
negatively impacting the observed relative abundance.
alue (relative abundance)
74
4)
343
(3)
389
(5)
48
42)
200
(95)
217
(40)
246
(15)
263
(60)
343
(30)
360
(20)
46
80)
263
(5)
292
(8)
309
(3)
00
12)
245
(100)
291
(5)
18
30)
246
(35)
ion (i.e., skimmer cone collisional activation).) of t
quad
m/z
(7)
(10)
(10)
(22)
(-)
(5)
(12)
r ITM
on sc
ay be
m/z v
2
(
1
(
2
(
2
(
2
(
ctivat
2, [M
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neamine structure for the 87 ion, or incorporation of
deuterons into the alkyl portion of the lysine side chain,
replacing non-labile (i.e., “non-exchangeable”) carbon-
bonded hydrogen atoms, in the case of the 88 ion (see
Figure 2). This high degree of isotopic scrambling is
indicative of considerable mobility among the deuter-
ons and is a reflection of the relatively long time
required for the formation of the m/z 84 ion.
The previous fragmentation study of lisinopril noted
the significant abundance of the m/z 246 signal in the
ESI mass spectrum obtained at high values of cone
voltage (one of the characteristic experimental parame-
ters for the particular instrument on which the experi-
ments were conducted). This observation prompted the
investigators to probe its structure in a sequential CID
experiment. Rationalization of the ensuing product ion
structures (m/z 218, 200, and 142) led to a proposal for
the structure of the 246 ion that required an unusual
carbon-carbon bond scission of the butylamine side
chain of the lysine residue, elimination of ethylamine
(Scheme 3). The structure of 246 (C14H16NO3
) re-
ported by Floreˆncio et al. requires the elimination of
proline (C5H9NO2) and ethylamine (C2H7N). The calcu-
lated m/z value for C14H16NO3
 is 246.1125, while the
measured m/z value for the observed lisinopril product
ion was determined to be 246.1495. These two values
differ by approximately 135 ppm, indicating a low
probability that the 246 ion has the empirical formula
(and structure) proposed in the previous lisinopril
study. If instead of proline and ethylamine, protonated
Scheme 2. Proposed mechanisms for the elimin
dissociation product of labeled lisinopril, m/z 41lisinopril produces m/z 246 product ions through the
consecutive losses of ammonia, proline and carbon
monoxide, the resulting ion would have an empirical
formula of C15H20NO2
, with a calculated m/z value of
246.1489. The agreement of the measured and calcu-
lated values (accuracy 2.4 ppm; standard deviation
1.0 ppm), supports the proposed fragmentation path-
way. The major dissociation products of m/z 246 result
from elimination of styrene, producing the product ion
at m/z 142 (C15H20NO2
, calculated m/z  142.0845,
measured m/z  142.0851, accuracy  2.8 ppm; stan-
dard deviation  6.7 ppm), and the sequential losses of
CO, producing the product ion at m/z 218 (C14H20NO
,
calculated m/z  218.1545, measured m/z  218.1536,
accuracy  4.1 ppm; standard deviation  5.3 ppm),
and H2O, producing the product ion at m/z 200
(C14H18N
, calculated m/z  200.1495, measured m/z 
200.1434, accuracy  30.5 ppm; standard deviation 
16.8 ppm). The product ion at m/z 200 could also result
from a competing concerted process (loss of formic acid,
HCO2H) that cannot be ruled out as the source of a
portion of the 200 ion population. It seems likely that
the original proposal of a ketene structure for the m/z
246 ion was due in part to the facility with which such
an ion might eliminate CO, producing the subsequent
product ion at m/z 218. Once the ketene structure is
ruled out on the basis of exact m/z measurements, the
only plausible mechanism for decarbonylation requires
a hydroxyl group transfer. This event would represent
the second occurrence of an intramolecular rearrange-
ment occurring in the dissociation cascade of proton-
of deuterium-labeled neutrals from the m/z 248
-d5  D]
.
ation
and r
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 H]).
The CID product ion spectra of both [lisinopril-d0]H

and [lisinopril-d5]D
 revealed evidence of considerable
mobility amongst the labile hydrogens/deuterons, par-
ticularly the ionizing H/D. To gain some additional
insight into the unimolecular dissociation processes, the
sodium ion attachment products (i.e., [lisinopril-
d0]Na
, m/z 428 and [lisinopril-d5]Na
, m/z 433) were
subjected to the same collisional activation conditions
used to interrogate the protonated/deuterated mole-
cules. The highest mass dissociation product observed
(m/z 331/336) results from the elimination of C5H7NO,
indicating that the mechanism responsible for the func-
tional group transfer reaction of OH (or possibly
CO2H) remained operative in the absence of an ion-
izing proton/deuteron. Notably absent from the spectra
of the sodiated ions are the three highest mass product
ions, corresponding to the competitive and consecutive
losses of NH3 and HCO2H (m/z 389, 360, and 343, Figure
2). The scission of the amide bond is responsible for the
next signal (m/z 313/316) in the product ion spectrum,
through elimination of neutral proline (C5H9NO2/
C5H7D2NO2). Although this ion nominally corresponds
to the b-ion of the protonated lisinopril molecule, there
appear to be several interesting differences. The elimi-
nation of proline-d2 from the [lisinopril-d5]Na
 ion
indicates mobility among the labile deuterons, with one
of the other exchanged deuterons being transferred to
(and eliminated with) the proline nitrogen atom. Sub-
sequent loss of CO from the b ion (313 3 285)
produces the peptide a ion, a dissociation channel that
Scheme 3. Comparison of dissociation pathway
collisional activation from protonated lisinopril.
ments obtained in the present study (left side),is observed for both protonated and sodiated lisinopril
species. Thus far, all of the reaction channels observed
in the product ion spectrum of sodiated lisinopril
corresponded to analogous processes of the protonated
species. The first deviation from that similarity of
behavior was exemplified by the appearance of the m/z
266 ion in Figure 3, upper panel. Cleavage of the
carbon-nitrogen bond (with associated hydrogen atom
transfer) at the terminal nitrogen atom of the lysine
residue liberates phenylbutenoic acid (Mr  162), ex-
plaining the 266 signal. Two interesting observations
regarding this dissociation process are (1) its absence
the m/z 246 ion obtained via sequential steps of
osed structures are based on exact m/z measure-
eported in a previous study (right side).
Figure 3. Product ion collision-induced dissociation (CID)
MS/MS spectrum for the [M-d0  Na]
 ion (m/z 428) (upper
panel) and [M-d  Na] (m/z 433) (lower panel) of lisinopril.s for
Prop5
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and (2) it being another example of deuteron mobility
during the CID process. The lack of a mass shift for the
neutral loss product (Mr  162, comparing the spectra
in the upper and lower panels of Figure 3) means that
the deuteron attached to the carboxylic acid hydroxyl
oxygen atom of the phenylbutyric acid undergoes an
intramolecular back exchange reaction. Thus, the phe-
nylbutenoic acid molecule liberated from the [lisinopril-
d5]Na
 ion contains no deuterons. Differences in the
fragmentation behavior of the protonated and sodiated
species continued to be evident with the observation of
the abundant signal at m/z 202 in Figure 3, and the
absence of a corresponding signal in the upper panel of
Figure 2. This fragment ion is the product of bond
scission between the N-terminal nitrogen atom and the
-carbon of lysine, with retention of charge (Na) on
the 2-amino-4-phenylbutyric acid. The product ion
spectrum of the deuterium-exchanged ion shows reten-
tion of three deuterons in the corresponding ion at m/z
205. This result is consistent with the proposed struc-
ture and shows no evidence of any unexpected mobility
(i.e., unanticipated exchange or back exchange) among
the deuterons associated with the two heteroatoms (N
and O). The next two lower mass ions (m/z 169 and 151)
in the product ion spectrum of sodiated lisinopril are
most likely the products of sequential dissociation
events involving the m/z 266 ion discussed earlier (428
3 2663 169 and 4283 2663 151). Those ions
are produced by elimination of C5H7NO (Mr  97) and
proline (C5H9NO2, Mr  115). These assignments are
consistent with processes observed for the [M  H] of
lisinopril, namely those responsible for the formation of
the product ions at m/z 309 and 291 (Figure 2). The most
abundant ion in the product ion spectrum of protonated
Table 2. Summary of collision-induced dissociation (CID) produ
esters. The fragmentation information is categorized and arrange
descending order of mass-to-charge ratio values. A threshold val
spectra represented in the table
ACE inhibitor esters y" ion
y  ion
minus
formic
acid a ion
a ion
minus
ethyl-
formate
a
m
st
m/
Enalapril, 10, mw
376
234 (100) 160 (23) 13
Perindopril, 11, mw
368
170 (15) 172 (100) 98 (19)
Trandolapril, 12,
mw 430
170 (9) 234 (100) 160 (6) 13
Ramipril, 13, mw
416
156 (4) 234 (100) 160 (8) 13
Quinapril, 14, mw
438
234 (100) 160 (10) 13
Moexipril, 15, mw
498
238 (4) 192 (2) 234 (100) 160 (5) 13lisinopril (m/z 84) has no analogous signal in the prod-
uct ion spectrum of the sodiated species. The absence of
this signal confirms the importance of protonation at
the amine nitrogen atom of the lysine side chain as a
pivotal step in the formation of not only the 84 ion, but
also the three product ions with m/z 389, 360, and 343.
The conclusion to be drawn from the dissociation
behavior induced by the two different charge bearing
species (proton vs. sodium cation) is that they attach to
the analyte molecule at several locations (competi-
tively). The resulting ion populations of mixed struc-
tures can access various competitive fragmentation
channels. The data also indicate that the two different
ionizing species exhibit varying degrees of mobility
after collisional excitation. Both of the deuterated spe-
cies ([lisinopril-d5]D
 and [lisinopril-d5]Na
) displayed
varying degrees of isotopic scrambling, mobility or
back exchange, but there are fewer instances of this
behavior when charge is imparted by a sodium cation.
Like lisinopril, all but one of the thirteen remaining
compounds are N-blocked dipeptides (see Figure 1).
The N-terminal blocking group is either ethylphenylbu-
tyrate or phenylbutyric acid in ten of the molecules, and
ethylbutyrate or ethylbutyric acid in the other two.
Twelve of the compounds possess the amino acid
alanine as the N-terminal residue, taking the place of
the lysine residue in lisinopril. The high degree of
homology in these compounds was reflected in their
product ion spectra. However, while these molecules
are similar, among twelve of the compounds the C-
terminal residue position is occupied by five different
amino acids. The positive CID product ion spectra of all
fourteen ester and acid ACE inhibitor compounds ([M
 H] 3 products) are summarized in Tables 2 and 3.
Because of the various structural differences that man-
n MS/MS spectra of the [M  H] ions for six ACE inhibitor
dissociation processes rather than the typical ascending or
2% relative abundance was used in summarizing the CID
c ion
(blocked
NH2 group)
c ion
(blocked
NH2 group)
minus
ethyl-
formate
loss of
ethyl-
formate
N-blocking
group minus
ethylformate
Loss
of
C5H2NO
ative abundance)
) 206 (4) 134 (11) 303 (29) 117 (9)
144 (2) 72 (8) 295 (12)
) 134 (6) 357 (4) 117 (3)
) 134 (5) 343 (19) 117 (3)
) 134 (7) 365 (5) 117 (4)
134 (4) 425 (4) 117 (2)ct io
d by
ue of
ion
inus
yrene
z (rel
0 (23
0 (12
0 (11
0 (15
0 (9)
he te
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ated molecules and diagnostic product ions, the infor-
mation contained in these tables is presented according
to the types of processes responsible for their formation
or appearance rather than being displayed in the con-
ventional fashion of ascending or descending order
according to the magnitude of the m/z value.
The ACE inhibitor ester CID spectra shown in Table
2 are all dominated (base peak) by the signal represent-
ing the a ion. In peptide product ion spectra, this signal
is often attributed to b ion formation followed by
subsequent loss of carbon monoxide. However, none of
the spectra showed any evidence of b ion formation.
While the absence of a signal for the intermediate
product of a sequential series of dissociation reactions
does not necessarily rule out the existence of the two-
step process (concerted elimination of proline and car-
bon monoxide), the lack of any evidence of b ion
formation for the six molecules in the data set appears
to support direct formation of the a ion (direct cleavage
and loss of N-formylproline). Most of these compounds
undergo the same six major decomposition reactions.
Four of these reaction channels involve the elimination
of ethylformate, a major portion of the N-terminus
blocking group. A fifth important pathway results in
the expulsion of styrene from product ions (largely a
ions) that contain the ethylphenylbutyrate N-blocking
group. The final significant decomposition mode of the
ACE inhibitor esters produces the familiar y ions that
provide primary amino acid sequence information for
polypeptides and proteins. Taken together these six
dissociation processes account for the majority of the
remaining signal intensity (aside from the base peak) in
the CID spectra of these molecules. This fact is striking
in that there is no intrinsically basic site (i.e., site of
charge localization) in the N-terminal blocking group(s)
that would serve as the focal point for charge induced
(directed) fragmentation. Therefore, these processes are
either charge-remote in nature or there is the same type
and degree of proton mobility that was evident in the
lisinopril results. The other notable feature shared by
Table 3. Summary of collision-induced dissociation (CID) produ
or descending order of mass-to-charge ratio values. A threshold v
ACE inhibitor acids y  ion
y  ion
minus
formic acid a ion
Lisinopril, 1, mw 405 263 (9
Enalaprilat, 2, mw 348 206 (1
Perindoprilat, 4, mw 340 170 (70) 144 (1
Trandolaprilat, 5, mw 402 170 (68) 206 (1
Ramiprilate, 6, mw 388 156 (38) 206 (1
Quinaprilat, 7, mw 410 178 (17) 132 (4) 206 (1
Moexiprilate, 8, mw 470 238 (52) 192 (9) 206 (1
Note: The distinct dissociation reactions of captopril are discussed in tthe six CID spectra summarized in Table 2 is the
absence of the rearrangement/elimination process re-
sponsible for the formation of the interesting m/z 309
ion (loss of C5H7NO) in the lisinopril product ion
spectrum.
The six acid ACE inhibitors (summarized in Table 3)
show fragmentation behavior very similar to that of
their ester analogs. The base peak in all of these CID
spectra is attributable to the a ion. For the five com-
pounds containing the phenylbutyric acid N-terminus
blocking group, this ion is m/z 206, while for the
remaining member of the group (perindoprilat, with
butyric acid as the blocking group) the ion is m/z 144. Of
the other dissociation processes exhibited by the acid
compounds, the loss of formic acid (analogous to the
elimination of ethylformate) is prevalent, participating
in four of the six remaining significant decomposition
channels. The other two processes that merit mention
are the loss of styrene and the formation of y ions. Once
again, it is clear that most of the product ions are
originating from that portion of the molecules originally
comprising the N-terminal blocking group of the dipep-
tide structure. As mentioned in the discussion of the
dissociation behavior of the esters (vide supra), the
expulsion of formic acid (like that of ethylformate from
the ester compounds) must either be charge remote in
nature, or dependent upon mobile protons. Strikingly,
the rearrangement/elimination process responsible for
the formation of the interesting m/z 309 ion (loss of
C5H7NO) in the lisinopril product ion spectrum is
absent from the CID spectra of all the other compounds.
Obviously, the structure of the C-terminal amino acid
residue has no bearing on the functional group transfer
that facilitates loss of that residue. Given the high
degree of similarity among the other structural ele-
ments of the various molecules, it seems clear that the
presence of the primary amine group in the side chain
of the N-terminal residue (i.e., lysine vs. alanine) was
the pivotal factor responsible for the interesting frag-
mentation behavior of lisinopril. If protonation at the
amide group [23] were responsible for initiating the
n MS/MS spectra and the [M  H] ions for seven ACE
of 2% relative abundance was used in summarizing the CID
a ion
minus
formic acid
a ion
minus
styrene
b ion
minus
formic acid
c ion
(blocked
NH2 group)
c ion
(blocked
NH2 group)
minus
formic acid
m/z (relative abundance)
160 (53) 102 (32) 178 (6) 134 (8)
98 (54) 124 (7) 116 (14)
160 (15) 102 (15) 124 (7) 134 (7)
160 (24) 102 (15) 134 (8)
160 (20) 102 (14) 134 (7)
160 (10) 102 (9) 134 (6)
xt.ct io
alue
)
00)
00)
00)
00)
00)
00)
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C5H7NO) proposed in the previous lisinopril study, this
mechanism should be operative for all of the analogs
shown in Tables 2 and 3, and yet this is clearly not the
case. It has been suggested that the requisite amide-
protonated structure is arrived at after initial protona-
tion of the lysine amine group and some subsequent
“interaction” or “sharing/transfer” of the ionizing pro-
ton. Such an interaction requires an unusual nine-
centered transition state geometry and an endothermic
proton transfer, due to the considerable proton affinity
differences between primary amines and amides. Both
of these requirements seem improbable. If instead, the
elimination of C5H7NO from lisinopril was dependent
upon the transfer of the proline carboxylic acid group to
the N-terminal nitrogen atom of lysine (as proposed in
the alternative mechanism shown in Scheme 1), that
nitrogen atom must not bear the ionizing proton. If that
nitrogen atom were the site of protonation, the resulting
positive charge would prevent electrophilic attack of
the carboxylic acid group carbonyl carbon atom and
therefore prevent the rearrangement. Alternatively,
when protonation occurs primarily or preferentially at
the side chain amino group, the lysine N-terminal
Table 4. Summary of collision-induced dissociation (CID) produ
acids. The fragmentation information is categorized and arranged
descending order of mass-to-charge ratio values. A threshold val
spectra represented in the table
ACE inhibitor acids y ion fo
m/z (relati
Lisinopril, 1, mw 405 114 (100)
Enalaprilat, 2, mw 348 114 (100)
Captopril, 3, mw 217 114 (100)
Perindoprilat, 4, mw 340 168 (100)
Trandolaprilat, 5, mw 402 168 (100)
Ramiprilat, 6, mw 388 154 (100)
Quinaprilat, 7, mw 410 176 (100)
Moexiprilat, 8, mw 470 236 (100)
inhibitor acids. The fragmentation information is categorized and
spectra represented in the table
loss of
formic acid
N- blocking
group
minus
formic acid
loss of
C5H7NO loss of NH3
360 (6) 309 (18) 389 (2)
303 (30) 117 (13)
295 (17)
357 (5) 117 (7)
343 (20) 117 (8)
365 (5) 117 (8)
425 (2) 117 (5)nitrogen atom retains its basic character and its ability
to serve as a receptor for the carboxylic acid functional
group that must be transferred in order to enable the
elimination reaction.
Captopril, 3 (the first member of the ACE inhibitor
therapeutic class) constitutes a special case, possessing a
very simple structure that includes the acyl proline
moiety that is common to several members of the class,
but not the second amino acid residue. The simple and
distinct nature of its structure (branched alkyl thiol) is
reflected in the CID product ion spectrum of the pro-
tonated molecule. The fragmentation processes are
dominated by the elimination of N-formylproline ([M
H  R1CHO]
, m/z 75) with charge retention on the
alkyl thiol side chain. Proline also figures prominently
in the formation of product ions at m/z 70, 103, and 116,
either through its elimination (m/z 103), it’s elimination
with subsequent loss of formic acid (m/z 70) or retention
of charge to yield m/z 116. The elimination of formic
acid from the protonated molecule is also likely to be
the source of the ion at m/z 172, although loss of
thioformaldehyde would also fit for that nominal mass.
The low m/z value region of the spectrum exhibits
signals for protonated thioformaldehyde (m/z 47) and
n MS/MS spectra of the [M  H] ions for eight ACE inhibitor
issociation processes rather than the typical ascending or
5% relative abundance was used in summarizing the CID
of CO2
thio-
ldehyde
loss of
hydrogen
sulfide [M  H]
undance)
(20) 182 (20) 216 (12)
nged by dissociation processes rather than the typical ascending
loss of NH3
and formic
acid
a ion minus
NH3
a ion minus
ammonia
and formic
acid
a ion minus
ammonia
and phenyl-
propenoic
acid
343 (8) 248 (73) 200 (6) 84 (100)ct io
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). The absence of a favorable
receptor site and the inability to form a favorable five-
or six-centered transition state geometry explains why
no C5H7NO is eliminated from captopril.
Negative Ion Study
Negative ion detection is employed to enhance sensi-
tivity and selectivity of mass spectral analyses. While
not as widely used as positive ion detection, due to the
smaller number of compounds that form stable anions,
negative ion detection can be particularly useful for
specific compound classes (e.g., carboxylic acids). In
addition to their analytical utility, the unimolecular
dissociation chemistry of negative ions can also be
unique and interesting. The site of charge localization
(most commonly as a consequence of deprotonation,
although radical anions are favored for particular
classes of molecules) in anions is generally quite differ-
ent from the site of protonation. Consequently, the
fragmentation pathways observed for anions can pro-
vide complimentary structural information of either
analytical or fundamental interest.
The CID product ion spectra obtained for the anions
([M  H]) of the eight acid ACE inhibitors were
strikingly simple in their appearance (Table 4). Under
the same experimental conditions that produced a se-
ries of structurally informative product ions for the
protonated acid molecules, the anions of all the com-
pounds but captopril yielded spectra exhibiting only a
single signal—the deprotonated C-terminus amino acid
residue. This observation is interesting for a number of
reasons. Localization of charge at the C-terminal car-
boxylate group indicates that scission of the amide
bond is not charge directed, with bond cleavage and
associated hydrogen transfer occurring some distance
from the site of deprotonation. Also, the presence of
two carboxylic acid groups in these molecules raises the
possibility of competitive sites of deprotonation (ioniza-
tion). Each of the acid functional groups is located  to
a nitrogen atom, one an amide nitrogen atom and the
other a secondary amine nitrogen atom. The impact of
these two chemically distinct nitrogen atoms on the
relative acidity of the two COOH groups is clear.
Deprotonation of the C-terminal acid group appears to
dominate, as reflected by the absence of any dissocia-
tion channels attributable to deprotonation of the N-
terminus blocking group carboxylic acid. The appear-
ance of only the y ion in the fragmentation spectra of
these compounds limits the utility of negative ion mode
investigations from a structure elucidation perspective.
However, the specificity of molecular anion formation
for the carboxylic acid compounds coupled with the
limited number of dissociation channels makes for an
ideal scenario for detecting and quantifying these com-
pounds using selected reaction monitoring protocols,
such as those commonly employed in metabolism stud-
ies [15, 16]. Although it is relatively small in size and
simple in structure compared with the other com-pounds studied, the captopril molecular anion appears
to stabilize charge more effectively than those of the
other acids as indicated by its appearance in the prod-
uct ion CID spectrum. The captopril CID spectrum
contains two signals in addition to the y ion—elimina-
tion of hydrogen sulfide (m/z 182) and consecutive (or
concerted) losses of thioformaldehyde and carbon diox-
ide (m/z 126). The loss of CO2 from carboxylate anions is
an expected process, being both charge directed and
resulting in the elimination of a very stable, small
neutral molecule. Despite the high degree of similarity
between the acid ACE inhibitors, it is somewhat unex-
pected that none of the other molecules in the class
exhibit this unimolecular dissociation process.
Unlike the acid ACE inhibitors, the anions ([M 
H]) of the six esters produced CID product ion spectra
that were information rich, containing numerous sig-
nals. The spectra are summarized in Table 5 and show
not only a significant number of fragmentation chan-
nels, but also considerable diversity among the dissoci-
ation products. Among all of the types of ions examined
in this study under reasonably constant CID experimen-
tal conditions (i.e., consistency in collision energies and
target gas pressures), the molecular anions of the esters
show the greatest stability toward fragmentation. The
ester compounds exhibited relative abundances for the
[M  H] ions that ranged from 15–100%. The major
point of consistency between the CID spectra of the
ester and acid anions was the prominence of the signals
representing the y ion. All six of the ester compounds
exhibited robust signals for the carboxylate anion of the
C-terminal amino acid residue, ranging from 52–100%
relative abundance. The only other dissociation process
that was common to all of the compounds was the
formation of what is described as the z-ion (RCH2CO2
,
with fragmentation occurring between the -carbon
and the N-terminal nitrogen atom of the Ala residue),
which has undergone subsequent elimination of CO2.
The next most prevalent signal (displayed in the CID
spectra of four of the compounds) is the result of two
sequential (or concerted) dissociation processes involv-
ing the C-terminal residue and the N-terminal blocking
group. This combined loss of the C-terminal residue as
the neutral amino acid and the ester portion of the
blocking group as ethylformate results in the appear-
ance of a m/z 186 signal in the product ion CID spectra
for the anions of Compounds 10, 13–15. The elimination
of the C-terminal residue as the neutral amino acid
requires the transfer of two hydrogen atoms and local-
ization of the negative charge in a portion of the
molecule that does not appear particularly well suited
to stabilize it. While this unimolecular dissociation
process would be more easily accommodated by a
precursor ion structure having the charge localized
initially at a site other than the carboxylate group (e.g.,
loss of a proton that is  to a carbonyl group or
deprotonation of the secondary amine), the formation
of such an ion during the ESI process would be unusual.
It seems far more probable that charge migration occurs
1312 BURINSKY AND SIDES J Am Soc Mass Spectrom 2004, 15, 1300–1314upon collisional activation through the movement of
one or more mobile protons. Upon initial inspection, the
elimination of ethylformate from the N-terminus block-
ing group (either ethylpentanoate or ethylphenylbu-
tyrate) would seem to be charge remote in its origin.
However, a charge directed process can be envisioned
through deprotonation not at the carboxylate hydroxyl
oxygen but rather at the carbon atom  to the ester
carbonyl carbon atom (i.e., enolate anion formation) or
deprotonation of the adjacent secondary amine. The
formation of enolate anions from esters is not uncom-
mon under classical chemical ionization conditions [25],
but requires strongly basic reagent ions, since the acid-
ity of the protons positioned  with respect to the ester
carbonyl group is low (i.e., differs by several orders of
magnitude) in comparison to that of carboxylic acids.
Thus, formation of such an enolate under normal elec-
trospray ionization conditions is not favored. Similarly,
the relative acidities (pKa) of the proline carboxylic acid
group and the blocked terminal amine group of alanine
differ by many orders of magnitude in favor of the
carboxylic acid. Consequently, the elimination of the
ethylformate may be charge directed, but only after the
requisite proton transfer reactions, since initial depro-
tonation of the secondary amine seems unlikely. The
elimination of ethylformate also figures prominently in
six additional fragmentation processes described in
Table 5. The combined elimination of ethylformate and
carbon dioxide produces signals in the CID spectra of
Compounds 10, 11, 14, and 15, while only two of the
compounds exhibit signals for the ethylformate loss
alone. None of the compounds show a loss of either the
neutral C-terminal residue or CO2 without the accom-
panying ethylformate loss. Inexplicably trandolapril,
12, exhibits none of these dissociation processes despite
its high degree of structural homology with Com-
pounds 11 and 13.
The remainder of the ion current in the fragmenta-
tion spectra of the six ester anions summarized in Table
5 is distributed among more than a dozen reaction
channels that show little similarity or consistency
among the various compounds, despite their structural
similarities. Many of these decomposition reactions
appear in the spectrum of only a single member of the
series of compounds, and most produce ions having
low to moderate abundances. Some of these signals are
indicative of the structural diversity in the C-terminal
residue, such as the loss of formaldehyde molecules
from the dimethoxy substituted quinoline of moexipril.
Other signals appear to represent radical anions and
their intensities indicate considerable stability for those
structures. The complexity of the CID spectra of the
ester anions is somewhat remarkable when compared
to the very simple spectra obtained for the ester cations
or the diacid anions. Some of the uncommon, unfamil-
iar and interesting dissociation channels (including
possible rearrangements) that are accessed by the acti-
vated/decomposing ACE ester anions will require fur-
ther study and investigation.Conclusions
The ACE inhibitors constitute an important class of
therapeutic molecules that display interesting unimo-
lecular chemistry upon low energy collisional activa-
tion. A specific rearrangement mechanism observed for
one of the members of this class (lisinopril) has been
explored in detail through the use of product ion CID
spectra, deuterium exchange, sequential dissociation
reactions (MS3) and exact m/z measurements. Despite a
high degree of similarity among the related compound
structures examined in this study, only lisinopril dis-
played the unusual rearrangement. Several additional
decomposition channels of protonated lisinopril (i.e.,
formation of m/z 246 and its subsequent dissociation
products) were also examined using exact m/z measure-
ments and found to differ from a proposal put forth by
the authors of a previous study. The significant impact
of the side-chain amino group of the lysine residue on
the unimolecular dissociation chemistry was evident
from the CID processes exhibited both by protonated
([M  H]) and sodiated ([M  Na]) lisinopril. Sub-
stitution of the charge carrying proton with sodium had
no effect on some of the decomposition reactions,
producing analogous product ions (differing only in the
mass of the charge carrier). In other instances however,
the absence of the ionizing proton completely elimi-
nates certain dissociation pathways. Most notable
among these suppressed fragmentation cascades are
those initiated by the elimination of ammonia—due
either to differences in the site of attachment, relative
binding strengths or mobilities for the two different
ionizing particles.
The previously unreported CID product ion spectra
of the anions ([M  H]) of the ACE inhibitors, exhib-
ited a number of interesting attributes. The seven diacid
molecules, 1, 2, 4–8 (i.e., those compounds possessing
carboxylic acid functional groups at both the C-termi-
nus and in the N-terminus blocking group) displayed
surprisingly simple spectra that showed only a single
signal, the deprotonated C-terminal amino acid residue
(y ion). These spectra have limited utility from the
perspective of structure elucidation, but are ideal for
analytical applications that employ selected reaction
monitoring (SRM). The six ACE inhibitor ester mole-
cules, 9–14, yielded unexpectedly complex dissociation
spectra, displaying numerous decomposition channels
not observed for the corresponding diacids. They reflect
a scenario where no one decomposition channel domi-
nates. Like the diacids, the deprotonated ACE esters
yield abundant y ions. These ions are indicative of
formation and retention of charge (deprotonation of the
carboxylic acid) at the most probable site in the mole-
cule. They provide a rapid means of confirming the
identity of the analyte in question, since much of the
homology in this compound class is present in the
structure of the C-terminal amino acid. The only other
signals common to the CID spectra of all six of these
compounds represent the decarboxylated z ion (z-ion
Table 5. Summary of collision-induced dissociation (CID) product ion MS/MS spectra of the [M  H] ions for six ACE inhibitor esters. The fragmentation information is categorized
and arranged by dissociation processes rather than the typical ascending or descending order of mass-to-charge ratio values. A threshold value of 5% relative abundance was used in
summarizing the CID spectra represented in the table
ACE inhibitor esters y ion
y ion
minus CO2 z ion
z ion
minus CO2
loss of neutral
C-terminus
residue and
ethylformate
loss of
ethylformate
loss of
ethylformate
and CO2
loss of
ethylformate
and CH4 C7H7
 [M  H]
m/z (relative abundance)
Enalapril, 10, mw 376 114 (100) 126 (80) 186 (17) 301 (12) 257 (6) 91 (16) 375 (56)
Perindopril, 11, mw 368 168 (100) 124 (23) 180 (14) 249 (17) 367 (72)
Trandolapril, 12, mw 430 168 (100) 180 (12) 429 (15)
Ramipril, 13, mw 416 154 (73) 210 (10) 166 (65) 186 (17) 341 (7) 91 (8) 415 (100)
Quinapril, 14, mw 438 176 (43) 132 (7) 188 (95) 186 (14) 319 (100) 347 (32) 91 (10) 437 (47)
Moexipril, 15, mw 498 236 (52) 248 (29) 186 (10) 379 (94) 407 (17) 497 (70)
ACE inhibitor esters
y ion minus
formic acid
a  1
radical anion
z radical
anion
loss of ethyl-
pentanoate
loss of
ethylformate
CH4 and H2O
y ion minus 2
molecules of
formaldehyde
loss of
phenyl-
butenoic
acid
loss of
C6H5C2H4
radical
loss of
ethylformate,
CH4 and
styrene
loss of
ethylformate,
CH4, styrene
and H2O
m/z (relative abundance)
Enalapril, 10, mw 376 169 (34) 213 (10)
Perindopril, 11, mw 368 237 (6)
Trandolapril, 12, mw 430
Ramipril, 13, mw 416
Quinapril, 14, mw 438 130 (10) 329 (18) 243 (25) 225 (13)
Moexipril, 15, mw 498 233 (100) 176 (34) 392 (23) 303 (28)
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 H]). The lack of commonality or consistency among
the remaining signals summarized in Table 5 was
unexpected and requires additional study.
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